Neuroscience Companies Worldwide

Ingen.io creates context and surfaces named entities (people, companies, products, etc.) that are not explicitly mentioned but are part of the broader narrative. All entities, stated or implied are represented in a Contextual Graph with information about their relationship type and weight of importance within the text. Products: Contextual API - provides NER and extracts context, Language Detection API, Part Of Speech tagging API

MindProber is a media measurement solution that gives content producers, distributors, and brands the ability to measure the emotional impact their content has on consumers to optimize advertising and content decisions.

Aequicens was founded at the start of 2018 in Geneva, Switzerland. Aequicens takes a scientific approach to artificial intelligence-based analytics. We rigorously test our solutions before making them available. We build new intelligence and support your business through the innovation circle. We also rely on thinking outside the box to find new ways to compress, abstract, and preprocess data to ensure only the pertinent information is used to construct our models. Underneath it all, we are a knowledge company, not only a technology company, we sell understanding. Our philosophy is to use artificial intelligence when it is useful, not just impressive.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

We take immersion to innovative heights. Our soft robotic interfaces interact with the skin, combining temperature, pressure and vibration to create a realistic tactile experience while proprietary algorithms mimic how the brain merges touch with vision, sound, proprioception and movement to create and restore lifelike multi-sensory experiences. Our technology creates a sensory experience with lived emotions, truly connecting the body with the digital world. Its uses in our daily lives are limitless.

Metrion Biosciences is a UK-based Contract Research Organization specialising in high quality ion channel screening and drug development expertise. We aim to provide our customers with access to a range of in vitro screening services that includes cardiac safety (hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis. We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, our management team have amassed over 80 years of experience in ion channel drug discovery and our clients can access this high level of expertise as part of our dedicated service.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body.

Drive revenue with our world-class neuromarketing toolbox. - Increase conversions & pre-test visual assets in seconds with 𝗣𝗿𝗲𝗱𝗶𝗰𝘁 𝗔𝗜 - Reveal real emotions & motivations behind your creatives with 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 - Get granular behavioral data & run full-scale studies with 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 Top brands use Neurons to predict customer behavior & improve performance.

Our mission at OVOMIND is to transform the game experience by making emotions a crucial component of interaction. We do this by using smartbands to read players' biosignals, which creates an unmatched enhanced augmented reality gaming experience. Get ready for an unforgettable and thrilling experience as you immerse yourself in a world where emotions and gaming collide.

Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases. Our platform uses patient genomes, gene expression, and epigenomics to identify new therapeutic gene targets, predict effective drugs, and stratify patient subpopulations for increased clinical success. Verge's approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally lower the cost curve of pharmaceutical development. We are looking for extraordinary individuals to join our motivated team in taking on our generation’s biggest healthcare challenges: ALS, Parkinson’s Disease, and Alzheimer's Disease. Our employees are our most important asset; we are a team of founders, excited to learn, roll up our sleeves, and make a real impact. The startup nature of Verge Genomics provides multiple growth opportunities into other areas of the company. As one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, on-site gym access, and free lunch. Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Bitbrain was founded in 2010 as a spin-off company of a research team from the University of Zaragoza, pioneer in approaching brain-computer interface applications outside laboratory investigation settings. Its DNA holds all knowledge in neurotechnology, biomedical engineering, artificial intelligence and data science accumulated at the university since 1998. Nowadays, the R+D+I bet is still strong, which has converted the company in a world reference for B2B neurotechnology solutions.

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. * Posts here are for information only without any warranty of any kind.

At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

Imaginostics is a health tech startup developing magnetic resonance imaging (MRI) technology, with locations in Cambridge, MA and Lake Nona, FL. We are developing non-invasive diagnostic solutions for renal-safe vascular angiography and breakthrough quantitative imaging biomarkers that can provide new insight into health and disease. We have a nimble, innovative, and growing team that embraces a bold vision to take breakthroughs in magnetic resonance imaging and transform them into a platform that can improve lives. Our proprietary QUTE-CE MRI methodology can non-invasively assay vascular structure, function, and leakage in high resolution anywhere in the body at the single-patient level, providing scientific and clinical researchers new endpoints for early detection and enhanced characterization of complex diseases. Data can be used to visualize the vasculature, assay health and disease, stratify research populations, support early preventative diagnostics, and help assess drug efficacy. We also provide biomarker solutions commercially through CROs to pharma and participate in pre-clinical and clinical research in a variety of focus areas collaborating with world-renowned researchers at leading institutions. Our technology and software are compatible with existing MRI scanners. Imaginostics’ research / development focus areas include: • Safe Full Body Vascular Enhanced Imaging for Renally Impaired Groups • Neurological Drug Characterization (Vascular Function, Density and Structure) • Biomarkers for Alzheimer’s Disease and Related Dementias (ADRD) • Traumatic Brain Injury (TBI) • Cardiovascular Biomarkers • Kidney Biomarkers Please reach out if you would like to explore opportunities to work together: • Pharmaceutical Companies • Hospitals • Academic Research Collaborators • Investors • Engineers and Researchers (please see current openings) To learn more, please visit: http://www.imaginostics.com

Better data. Better brains. Kernel is developing the world’s most comprehensive library of brain-based biomarkers and applying them to develop new treatments, improve patient care, and optimize brain function.

NerveX develops intelligent neuromodulation devices to repair and augment the nervous system

Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world. Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.

Amal Therapeutics is a Biotechnology company located in 64 av., de la Roseraie, 1205 Geneva, Switzerland.

With our expert facilitators and cutting-edge techniques, we equip your team with the necessary skills to promote psychological safety, reduce stress levels, and enhance teamwork. Our training program focuses on building resilience, open communication, and a growth mindset, ensuring a positive work environment for all. Don't wait any longer; invest in your employees' well-being and see the positive impact on your business. Join us at NeuroCapability, and let's create a safe and thriving workplace together!

Eridanus Healthcare is a neuropsychiatric pharmaceutical company established in 2012 with over 20 years of experience in delivering neuro products in India. We manufacture WHO-GMP certified neurological and psychiatric medicines in DCGI-compliant facilities. We offer PCD pharma franchise opportunities with exclusive monopoly rights, focusing exclusively on the neuropsychiatric segment with a pan-India presence from our base in Bathinda, Punjab.

Phracta delivers fresh perspectives to complex ecosystem challenges using fractal analysis with Wardley mapping and other sense-making techniques. Phracta models also enable organisations to safely incorporate Generative AI while enhancing trust.